- 专利标题： GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE
-
申请号： US15526593申请日： 2015-11-12
-
公开(公告)号： US20170306046A1公开(公告)日： 2017-10-26
- 发明人: Ana Paula Galvao daSilva , Darius Ghaderi , Mai Zhang , Kristan Meetze , Julie DeSander , Jeffrey Behrens , David A. Eavarone , Jillian M. Prendergast , Alexey Alexandrovich Lugovskoy
- 申请人： SIAMAB THERAPEUTICS, INC.
- 国际申请： PCT/US15/60287 WO 20151112
- 主分类号： C07K16/30
- IPC分类号： C07K16/30 ; C07K16/00 ; G01N33/574
摘要：
The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include monoclonal antibodies, derivatives, and fragments thereof as well as compositions and kits comprising them. Further provided are methods of using glycan-interacting antibodies to target cells and treat disease.
信息查询
